Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney
- PMID: 8824906
- DOI: 10.1007/BF01450878
Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney
Abstract
The urokinase-type plasminogen activator (uPA) is secreted into the urine at high concentrations and both the uPA protein and mRNA are present in human renal tissue. Normal kidney tissue also expresses the receptor for uPA. Neither the precise sites of uPA mRNA expression, nor the distribution of the uPA-receptor antigen, have been elucidated in the human kidney. In the present study, the sites of uPA mRNA expression were identified by in situ hybridization, and the cellular localization of both uPA and uPA-receptor was determined by immunohistochemical analysis. High-level uPA mRNA expression was restricted to epithelial cells of the convoluted proximal tubules and the thick ascending limb of Henle's loop (the straight part of the distal tubule). However, uPA immunoreactivity was not confined to sites of uPA mRNA expression, but was present in all segments of the tubular epithelium. Tubular epithelial cells also exhibited a consistent immunoreactivity with uPA-receptor antibody, indicative of a co-localization of the uPA antigen and its receptor in the uriniferous epithelium. We propose that the uPA antigen expression in nephron segments lacking demonstrable endogenous uPA synthesis may be the result of a uPA-receptor-mediated uptake of uPA.
Similar articles
-
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.Am J Pathol. 1995 Jul;147(1):183-92. Am J Pathol. 1995. PMID: 7604879 Free PMC article.
-
In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.Oncol Rep. 2004 Oct;12(4):909-13. Oncol Rep. 2004. PMID: 15375521
-
Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.Oncol Rep. 2005 Sep;14(3):777-82. Oncol Rep. 2005. PMID: 16077991
-
Regulation and role of urokinase plasminogen activator in vascular remodelling.Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. doi: 10.1111/j.1440-1681.1996.tb01177.x. Clin Exp Pharmacol Physiol. 1996. PMID: 8911711 Review.
-
Urokinase-type plasminogen activator.Int J Biochem Cell Biol. 2007;39(4):690-4. doi: 10.1016/j.biocel.2006.10.008. Epub 2006 Oct 21. Int J Biochem Cell Biol. 2007. PMID: 17118695 Review.
Cited by
-
Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.Pediatr Nephrol. 2013 Aug;28(8):1227-34. doi: 10.1007/s00467-013-2439-2. Epub 2013 Mar 16. Pediatr Nephrol. 2013. PMID: 23503750
-
Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.Am J Pathol. 1999 Jun;154(6):1731-42. doi: 10.1016/S0002-9440(10)65429-6. Am J Pathol. 1999. PMID: 10362798 Free PMC article.
-
Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice.Biol Sex Differ. 2016 Jun 27;7:31. doi: 10.1186/s13293-016-0085-7. eCollection 2016. Biol Sex Differ. 2016. PMID: 27354902 Free PMC article. Review.
-
Association of urokinase gene 3'-UTR T/C polymorphism with calcium oxalate urolithiasis in children.Int Urol Nephrol. 2008;40(3):563-8. doi: 10.1007/s11255-008-9335-x. Epub 2008 Feb 1. Int Urol Nephrol. 2008. PMID: 18240004
-
Global analysis of gene expression in mammalian kidney.Pflugers Arch. 2005 Apr;450(1):13-25. doi: 10.1007/s00424-004-1368-0. Epub 2004 Dec 21. Pflugers Arch. 2005. PMID: 15611884 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous